Wednesday, December 9, 2020

New compound related to psychedelic ibogaine could treat addiction, depression

A non-hallucinogenic version of the psychedelic drug ibogaine, with potential for treating addiction, depression and other psychiatric disorders, has been developed by researchers.

from Top Health News -- ScienceDaily https://ift.tt/3gxFrI4

No comments:

Post a Comment

Most of the world isn’t getting enough omega-3

Most people worldwide aren’t getting enough omega-3, leaving a major gap between scientific recommendations and daily diets. Researchers emp...